Nitric Oxide Modulation of the Basal Ganglia Circuitry: Therapeutic Implication for Parkinson's Disease and Other Motor Disorders

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|10|7|777-791

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.10, Iss.7, 2011-11, pp. : 777-791

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mitochondrial Toxins in Basal Ganglia Disorders: From Animal Models to Therapeutic Strategies

By  

Current Neuropharmacology, Vol. 4, Iss. 1, 2006-01 ,pp. : 69-75

Bentham Science Publishers

Access to resources Recommend Favorite

Nitric Oxide and Dopamine Neurons. Implications for Parkinson's Disease

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 5, Iss. 3, 2005-09 ,pp. : 193-205

Bentham Science Publishers

Access to resources Recommend Favorite

Disorders of the basal ganglia and their modern management

By Schrag Anette   Quinn Niall  

Clinical Medicine, Vol. 33, Iss. 4, 1999-07 ,pp. : 323-327

Royal College Of Physicians

Access to resources Recommend Favorite

Nitric oxide scavengers as a therapeutic approach to nitric oxide mediated disease

By Fricker S.P.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 8, 1999-08 ,pp. : 1209-1222

Informa Healthcare

Access to resources Recommend Favorite

Apomorphine in the treatment of Parkinson disease and other movement disorders

By Gunzler Steven A  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 6, 2009-04 ,pp. : 1027-1038

Informa Healthcare

Access to resources Recommend Favorite